Acute intracerebral hemorrhage in intravascular lymphoma: A serious infusion related adverse event of rituximab

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 2, 2007, Pages 211-212

  Ganguly, Siddhartha ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; INTERCELLULAR ADHESION MOLECULE 1; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; AUTOPSY; B CELL LYMPHOMA; BRAIN; BRAIN BIOPSY; BRAIN HEMORRHAGE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS; CONVALESCENCE; CYTOKINE RELEASE; DRUG INFUSION; FEMALE; HUMAN; HUMAN CELL; INTENSIVE CARE UNIT; INTRAVASCULAR LYMPHOMA; LABORATORY TEST; LARGE CELL LYMPHOMA; LYMPHOMA; SKIN; TUMOR CELL DESTRUCTION;

ACUTE DISEASE; ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOPSY; BRAIN; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING;

EID: 34147120717     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000182463.57861.3c     Document Type: Article

References (4)

1. Davis T. Intravascular lymphoma presenting with cauda equine syndrome: treated with CHOP and Rituxan. Leuk Lymphoma. 2003;44:887-888.
2. Han K, Haley JC, Carlson, et al. Regression of cutaneous intravascular lymphoma with Rituximab. Cutis. 2003;72:137-140.
3. Byrd JC, Waseleno JK, Maneatis TJ, et al. Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance. J Clin Oncol. 1999;17:791-795.
4. Ponzoni M, Arrigoni G, Gould VE, et al. Lack of CD 29 (beta 1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol. 2000;31:220-226.